Drug intelligence / Profile preview

hepatitis A vaccine (inactivated) (Sinovac Biotech Ltd.)

Development stage
Phase 4
Lead developer
Sinovac Biotech
Modality
Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

Healive is an inactivated vaccine developed by Sinovac Biotech for the prevention of Hepatitis A. It is derived from the TZ8 strain of the Hepatitis A virus (HAV), which is propagated in human diploid cells, inactivated with formaldehyde, and adsorbed onto an aluminum hydroxide adjuvant. The vaccine is designed to stimulate the production of specific neutralizing antibodies, providing active immunity against HAV infection. It was the first preservative-free Hepatitis A vaccine developed in China and is approved for use in both children (from 1 year of age) and adults.

Brand names
Healive
Other names
inactivated hepatitis A vaccine
02

Targets

Hepatitis A virus capsid protein

Beyond the preview

Go deeper on hepatitis A vaccine (inactivated) (Sinovac Biotech Ltd.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hepatitis A vaccine (inactivated) (Sinovac Biotech Ltd.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call